--- title: InnoSer news description: Preclinical contract research organisation InnoSer, updating on new readouts, preclinical research models, preclinical drug development platforms and getting the most out of your preclinical research. --- [Skip to content](https://resources.innoserlaboratories.com/innoser-news#main-content) InnoSer International B.V Open main navigation Close main navigation - [Contact us](https://resources.innoserlaboratories.com/innoser-news#contact) [Contact us](https://resources.innoserlaboratories.com/innoser-news#contact) # Blog Lorem ipsum dolor sit amet, consectetur adipiscing elit. [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/ALS-models-1.png)](https://resources.innoserlaboratories.com/innoser-news/blog/available-als-in-vivo-models-for-preclinical-research) [Blog](https://resources.innoserlaboratories.com/innoser-news/tag/blog), [Neurology](https://resources.innoserlaboratories.com/innoser-news/tag/neurology) ## [Accelerating ALS Drug Development: InnoSer’s Available In Vivo Models for Preclinical Research](https://resources.innoserlaboratories.com/innoser-news/blog/available-als-in-vivo-models-for-preclinical-research) [Dominika Krakova](https://resources.innoserlaboratories.com/innoser-news/author/dominika-krakova) Jun 20, 2023 5:24:57 PM Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disorder lacking highly effective d... [Read more](https://resources.innoserlaboratories.com/innoser-news/blog/available-als-in-vivo-models-for-preclinical-research) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/Parkinsons-Disease-Models-2.png)](https://resources.innoserlaboratories.com/innoser-news/blog/parkinsons-disease-models-in-preclinical-drug-development) [Blog](https://resources.innoserlaboratories.com/innoser-news/tag/blog), [In Vivo](https://resources.innoserlaboratories.com/innoser-news/tag/in-vivo), [Neurology](https://resources.innoserlaboratories.com/innoser-news/tag/neurology) ## [In Vitro & In Vivo Parkinson’s Disease Models: Understanding Their Role in Preclinical Drug Development ](https://resources.innoserlaboratories.com/innoser-news/blog/parkinsons-disease-models-in-preclinical-drug-development) [Dominika Krakova](https://resources.innoserlaboratories.com/innoser-news/author/dominika-krakova) Jun 6, 2023 10:23:12 PM Parkinson’s disease (PD) is a complex neurodegenerative disorder that affects millions of people wor... [Read more](https://resources.innoserlaboratories.com/innoser-news/blog/parkinsons-disease-models-in-preclinical-drug-development) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/PKD-blogpost-.png)](https://resources.innoserlaboratories.com/innoser-news/blog/choosing-the-right-adpkd-model) [Blog](https://resources.innoserlaboratories.com/innoser-news/tag/blog), [Nephrology](https://resources.innoserlaboratories.com/innoser-news/tag/nephrology), [ADPKD](https://resources.innoserlaboratories.com/innoser-news/tag/adpkd), [in vivo services](https://resources.innoserlaboratories.com/innoser-news/tag/in-vivo-services) ## [Choosing The Right ADPKD Model for Advancing your Rare Disease Research](https://resources.innoserlaboratories.com/innoser-news/blog/choosing-the-right-adpkd-model) [Dominika Krakova](https://resources.innoserlaboratories.com/innoser-news/author/dominika-krakova) May 15, 2023 4:36:39 PM To support the development of new therapies for autosomal dominant polycystic kidney disease, we off... [Read more](https://resources.innoserlaboratories.com/innoser-news/blog/choosing-the-right-adpkd-model) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/Case-study-1.png)](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/a-novel-inflammation-and-fibrosis-model-in-the-field-of-nash-drug-repurposing) [Cardio-Metabolic](https://resources.innoserlaboratories.com/innoser-news/tag/cardio-metabolic), [In Vivo](https://resources.innoserlaboratories.com/innoser-news/tag/in-vivo) ## [A novel inflammation and fibrosis model in the field of NASH & drug repurposing](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/a-novel-inflammation-and-fibrosis-model-in-the-field-of-nash-drug-repurposing) [Dominika Krakova](https://resources.innoserlaboratories.com/innoser-news/author/dominika-krakova) Apr 11, 2023 6:35:16 PM Nonalcoholic steatohepatitis [Read more](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/a-novel-inflammation-and-fibrosis-model-in-the-field-of-nash-drug-repurposing) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/InnoSer-x-Sylics-.png)](https://resources.innoserlaboratories.com/innoser-news/news/innoser-expands-its-preclinical-neuroscience-expertise-with-the-acquisition-of-sylics) [laboratory technical support](https://resources.innoserlaboratories.com/innoser-news/tag/laboratory-technical-support), [in vivo services](https://resources.innoserlaboratories.com/innoser-news/tag/in-vivo-services), [News](https://resources.innoserlaboratories.com/innoser-news/tag/news) ## [InnoSer expands its preclinical neuroscience expertise with the acquisition of Sylics](https://resources.innoserlaboratories.com/innoser-news/news/innoser-expands-its-preclinical-neuroscience-expertise-with-the-acquisition-of-sylics) [Casey](https://resources.innoserlaboratories.com/innoser-news/author/casey) Jan 12, 2023 11:10:00 AM This strategic acquisition substantially expands InnoSer’s preclinical neurology portfolio, adding i... [Read more](https://resources.innoserlaboratories.com/innoser-news/news/innoser-expands-its-preclinical-neuroscience-expertise-with-the-acquisition-of-sylics) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/Inficure-PR@2x.png)](https://resources.innoserlaboratories.com/innoser-news/news/innoser-and-inficure-bio-liver-inflammation-fibrosis-mouse-model) [Cardio-Metabolic](https://resources.innoserlaboratories.com/innoser-news/tag/cardio-metabolic), [News](https://resources.innoserlaboratories.com/innoser-news/tag/news) ## [InnoSer and Inficure Bio enter partnership to increase accessibility of translational liver inflammation & fibrosis mouse model](https://resources.innoserlaboratories.com/innoser-news/news/innoser-and-inficure-bio-liver-inflammation-fibrosis-mouse-model) [Casey](https://resources.innoserlaboratories.com/innoser-news/author/casey) Oct 27, 2022 11:45:00 AM October 27th [Read more](https://resources.innoserlaboratories.com/innoser-news/news/innoser-and-inficure-bio-liver-inflammation-fibrosis-mouse-model) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/New-imagers-blog-cover@2x.png)](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/new-preclinical-cancer-imagers-likaf) [Blog](https://resources.innoserlaboratories.com/innoser-news/tag/blog), [contract breeding](https://resources.innoserlaboratories.com/innoser-news/tag/contract-breeding), [Events](https://resources.innoserlaboratories.com/innoser-news/tag/events), [FELASA Congress](https://resources.innoserlaboratories.com/innoser-news/tag/felasa-congress), [in vivo services](https://resources.innoserlaboratories.com/innoser-news/tag/in-vivo-services), [facility management](https://resources.innoserlaboratories.com/innoser-news/tag/facility-management), [In Vivo](https://resources.innoserlaboratories.com/innoser-news/tag/in-vivo) ## [InnoSer expands preclinical cancer readout capabilities through acquisition of new imagers.](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/new-preclinical-cancer-imagers-likaf) [Casey](https://resources.innoserlaboratories.com/innoser-news/author/casey) Sep 15, 2022 3:08:50 PM Getting closer to understanding cancer through the adoption of technological advancements is crucial... [Read more](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/new-preclinical-cancer-imagers-likaf) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/SINERGIA@2x-1.png)](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/discussing-innovation-and-the-pdxo-platform-at-sinergia-summer-school) [Blog](https://resources.innoserlaboratories.com/innoser-news/tag/blog), [Events](https://resources.innoserlaboratories.com/innoser-news/tag/events), [innovation](https://resources.innoserlaboratories.com/innoser-news/tag/innovation), [In Vivo](https://resources.innoserlaboratories.com/innoser-news/tag/in-vivo) ## [Discussing innovation and the PDX/O platform at SINERGIA Summer School](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/discussing-innovation-and-the-pdxo-platform-at-sinergia-summer-school) [Casey](https://resources.innoserlaboratories.com/innoser-news/author/casey) Jun 12, 2022 11:00:10 PM We strive to stay at the forefront of biotechnological developments and to constantly incorporate in... [Read more](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/discussing-innovation-and-the-pdxo-platform-at-sinergia-summer-school) [Blog](https://resources.innoserlaboratories.com/innoser-news/tag/blog), [contract breeding](https://resources.innoserlaboratories.com/innoser-news/tag/contract-breeding), [Events](https://resources.innoserlaboratories.com/innoser-news/tag/events), [FELASA Congress](https://resources.innoserlaboratories.com/innoser-news/tag/felasa-congress), [in vivo services](https://resources.innoserlaboratories.com/innoser-news/tag/in-vivo-services), [facility management](https://resources.innoserlaboratories.com/innoser-news/tag/facility-management), [In Vivo](https://resources.innoserlaboratories.com/innoser-news/tag/in-vivo) ## [Facility management and preclinical services discussed at the FELASA Congress](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/facility-management-and-preclinical-services-discussed-at-the-felasa-congress) [Casey](https://resources.innoserlaboratories.com/innoser-news/author/casey) Jun 5, 2022 3:32:05 PM Animal testing has played a critical role in the development of drugs, enabling us to ultimately obt... [Read more](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/facility-management-and-preclinical-services-discussed-at-the-felasa-congress) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/Asset-16@2x.png)](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/get-to-know-our-preclinical-drug-development-services-at-knowledge-for-growth) [Blog](https://resources.innoserlaboratories.com/innoser-news/tag/blog), [laboratory technical support](https://resources.innoserlaboratories.com/innoser-news/tag/laboratory-technical-support), [Events](https://resources.innoserlaboratories.com/innoser-news/tag/events), [in vivo services](https://resources.innoserlaboratories.com/innoser-news/tag/in-vivo-services), [In Vivo](https://resources.innoserlaboratories.com/innoser-news/tag/in-vivo) ## [Get to know our preclinical drug development services at Knowledge for growth](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/get-to-know-our-preclinical-drug-development-services-at-knowledge-for-growth) [Casey](https://resources.innoserlaboratories.com/innoser-news/author/casey) May 10, 2022 5:00:50 PM We are constantly looking for opportunities to exchange and develop ideas, as they are the foundatio... [Read more](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/get-to-know-our-preclinical-drug-development-services-at-knowledge-for-growth) First Prev [1](https://resources.innoserlaboratories.com/innoser-news) [2](https://resources.innoserlaboratories.com/innoser-news/page/2) [3](https://resources.innoserlaboratories.com/innoser-news/page/3) [4](https://resources.innoserlaboratories.com/innoser-news/page/4) [5](https://resources.innoserlaboratories.com/innoser-news/page/5) [Next](https://resources.innoserlaboratories.com/innoser-news/page/2) [Last](https://resources.innoserlaboratories.com/innoser-news/page/6) ## Drive people to your products and services Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Learn more facebook-f icon linkedin-in icon Twitter icon instagram icon - Menu Item 1 - Sub-menu Item 1 - Another Item - Sub-menu Item 2 - Menu Item 2 - Yet Another Item - Menu Item 3 - Menu Item 4 --- # InnoSer International B.V 123 Main Street, City, State 11111 Copyright © 2026,